ResultsIQ

ResultsIQ › Latest results › TruAlt Bioenergy Limited

TruAlt Bioenergy Limited Q2 FY26 results deck summary

NSE: TRUALT · BSE: 544545

Results deck of 11 Nov 2025, summarised by AI from the filing.

TruAlt Bioenergy reported Q2 FY26 total income of ₹129.61 cr and PAT of ₹-37.86 cr, with all five ethanol units expected to run at full 2,000 KLPD capacity from Q3.

Key takeaways

  1. Q2 result Total income ₹129.61 cr (Q2 FY25: ₹404.83 cr, -68% QoQ); PAT ₹-37.86 cr (Q2 FY25: ₹-18.60 cr, -104% QoQ).
  2. Guidance All five ethanol units expected to run at full 2,000 KLPD rated capacity from Q3, subject to receipt of CTO for Unit 5.

Original filing on BSE

TruAlt Bioenergy Limited Q1 FY27 results

As filed: Revenue ₹627 cr (+106% year on year), EBITDA ₹133 cr (+216% year on year), PAT ₹59.3 cr (+300% year on year), EBITDA margin 21.2% (+736 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹603 cr, EBITDA ₹131 cr, PAT ₹56.7 cr, EBITDA margin 21.7%. Not scored. No result for the same quarter last year. Share price after the results: −0.7% in 28 days (Nifty 500: +2.2%).
  • Q3 FY26: Revenue ₹703 cr, EBITDA ₹129 cr, PAT ₹66.0 cr, EBITDA margin 18.4%. Not scored. No result for the same quarter last year. Share price after the results: −6.8% in 30 days (Nifty 500: −3.2%).
  • Q2 FY26: Revenue ₹104 cr, EBITDA −₹12.0 cr, PAT −₹43.0 cr, EBITDA margin -11.5%. Not scored. No result for the same quarter last year. Share price after the results: −2.1% in 30 days (Nifty 500: +1.0%).
  • Q1 FY26: Revenue ₹294 cr, EBITDA ₹34.0 cr, PAT ₹0.0 cr, EBITDA margin 11.6%. Not scored. No result for the same quarter last year.

Past price moves after results do not indicate future moves. Not a recommendation.

TruAlt Bioenergy Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.